B · Normal
September 20th: Novo Nordisk will hold an investor day event next Monday and update its company strategy. Institutional shareholders urge it to develop new drugs, promote mergers and acquisitions, and reduce its reliance on weight loss drugs to cope with competition from Eli Lilly.
Comments